Research Chelation Therapy

Residents across Abbots Langley turned out in force yesterday evening in order to raise money for a five-year-old suffering from a rare blood disease.

Villagers were busy buying jewellery, scented candles and bubble bath from stalls inside the Swan Pub in College Road, while sizzling sausages were sold on an outside barbecue – all in order to raise money for Brooke Cornwell.

Brooke, of Breakspeare Close, Watford, suffers from Diamond Blackfan Anaemia, a disorder which means her bone marrow cannot produce enough red blood cells to carry oxygen around her body.

As a result she needs to have blood transfusions every three weeks and iron chelation therapy – to rid her body of excess iron caused by the transfusions.

Charitable duo Mandie Collingbourne, 31, and Kerri Chapman, 27, organised the event in order to send Brooke to Camp Sunshine in Maine, America, so that she can meet and interact with similar children, as well as see a specialist.

Mrs Chapman, of Jersey Farm, St Albans, said: “As a mother-of-two, when I heard about what Brooke has been through, I felt moved to help.

“She’s such a remarkable little girl, so, so brave. Mandie and I really wanted to help so we decided to hold this fundraiser in Abbots Langley so that she could go to Camp Sunshine.

“If we raise anything extra that will go towards paying for whatever else Brooke needs.

“The community has really come together to show their support, it’s very touching how people pull together when needed.

“We hope that we can make a difference to little Brooke’s life.”

A number of local businesses as well as store Costco donated items including toasters, kettles and Waterford crystal sets all of which were raffled off.

Brooke’s mother, Amber Cornwell, 29, said: “I can’t believe what Mandi and Kerri have done for us – it’s just amazing, the pair of them, they are amazing.

“We applied to the camp in Maine a couple of months ago and we’ve just found out Brooke has been offered a place – all we need to do now is raise a couple of thousand so that me, my husband and Brooke can fly over to America.

“Lots of people have turned out to support us – we couldn’t be more grateful.”

Villagers helped raise £2,004 for Brooke.

Back

© Copyright 2001-2010 Newsquest Media Group

http://www.watfordobserver.co.uk

DSM Nutritional Products Indonesia conducted a seminar entitled “DSM Poultry Forum: Updating Global Trend in Poultry Industry” in Jakarta on 12 May 2010.

The seminar was divided into 3 sessions of presentation. Before the presentation and as welcoming speech, Suaedi Sunanto, Sales Manager DSM Indonesia, introduced the company and spoke of its commitment to animal nutrition and health.

The first session was presented by Dr. Kelli H. Jones, Assistant Clinical Professor of Avian Medicine Poultry Research and Diagnostic Laboratory, College of Veterinary Medicine, Mississippi State University. Her presentation’s was entitle is “A Global Perspective on Current Health Issues in the Poultry Industry”. Focusing on Asia, Dr. Jones said that current animal health issues in Asia include IBV (Infectious Bronchitis Virus), leg problems (Rickets, Tibial Dyschondroplasia and Vertebral Osteoarthritis), CRD (Chronic Respiratory Disease), Coccidiosis, Salmonella, AI (Avian Influenza), Adenovirus (Inclusion Body Hepatitis), and tumors (Marek’s disease).

The second session was presented by Dr. Jose Maria Hernandez, Global Business Manager Poultry, DSM Nutritional Products – Switzerland, entitled “Food Chain Partnership: the DSM Experience”. Dr. Hernandez explained that main goal of food chain partnership is to ensure food safety and quality to consumers, but it depends on each stakeholder in the food chain. Based on DSM’s research to European consumers, he added that nowadays consumers are not sure about the safety of food they are eating and the companies and brands behind. “Consumers want information on how food is produced in order to regain their trust. That’s why, work with media and NGOs is important in gaining much power,” Dr. Hernandez said.

The last session was presented by Dr. Roselina Angel, Assistant Professor of Department of Animal & Avian Sciences, University of Maryland. Dr. Angel’s presentation is about amino acid digestibility in sorghum, kafirin in sorghum, phytic acid & phytin, and phosphor’s chelation. She also informed that she has been working together with an animal nutritionist from Indonesia to study palm kernel meal for one of alternative animal feedstuffs.

 

Source: newsroom – meattradenewsdaily

Health care simplified Doctors Prefer Cash. A new online directory is being launched in Arizona by Kevin Reilly and Bob and Dan Kauffman. A simple approach to healthcare.  Pay your doctor for his services eliminating the insurance companies  markup and limitations of service. Doctors Prefer Cash will be launced October 1st with a massive marketing campaign targeting local, radio, print ads, web marketing and direct mail. Take back control of health care. Is paying cash the answer? In some cases yes.  In today’s uncertain health and financial environment Doctors Prefer Cash is a healthy alternative. For more information
DoctorsPreferCash.com

Awaken Nutrition has been “picked up” – endorsed, that is – by Jenny McCarthy’s company, Generation Rescue, which has been a giant in autism therapy and research and nutritional products. Generation Rescue and Awaken Nutrition alike are both working hard helping those with special nutritional needs in conjunction with neuro-behavioral disorders.

Awaken Nutrition’s specially-formulated line of nutritional supplements allow those with special neurological and nutritional needs to receive the proper dietary balance for optimum health. Pairing up with Generation Rescue means that Awaken Nutrition will, of course, be able to reach many more children and adults with its specifically formulated line of supplement products. Products such as the gluten and casein-free Liquid Calcium Formula, the Colon and Liver Detox duo, and the chelation therapy spray for eliminating heavy metal toxicity and mercury toxicity are forerunners in promising nutritional hope where gimmicky diets and fly-by-night “cures” have failed those in need of alternative therapy.

Join Awaken Nutrition and Generation Rescue’s quest for healthy children and healthy lives!

Earlier this week, the Associated Press reported that Tom Insel, the director of the National Institute of Mental Health (NIMH), supports testing the effectiveness of chelation therapy on children to see if it can be proved safe and effective. The autism blogosphere lit up, and advocates of chelation therapy were elated. But as with all things concerning autism, alas, the story is far more complicated than it seems.

The chelation study was first approved by NIMH in 2006. In February 2007, a study showed that giving chelation to rats who weren’t suffering from heavy-metal poisoning caused permanent cognitive impairment. Whoa. That sent NIMH back to more risk-benefit analysis. It filed an application with the Food and Drug Administration to study chelation as an investigational new drug (an IND, in FDA-speak). And keep in mind that the dynamic of testing chelation on rats involves differing variables than on human beings. The findings are not “definitive” at all.

The knowledge gleaned from the study will be limited, since only 120 children are to be enrolled.  Half will get a chelating agent for 12 weeks and the other half, a placebo. The children’s blood mercury levels and autism symptoms will be monitored along the way. That’s too few subjects to get a clear sense of whether or not chelation works, though it’s better than what we’ve got now.

Chelating agents were introduced into medicine as a result of the use of poison gas in World War I. The first widely used chelating agent, the organic dithiol compound dimercaprol (also named British Anti-Lewisite or BAL), was used as an antidote to the arsenic-based poison gas, Lewisite. The sulphur atoms in BAL’s mercaptan groups strongly bond to the arsenic in Lewisite, forming a water-soluble compound that entered the bloodstream, allowing it to be removed from the body by the kidneys and liver. BAL had severe side-effects, such as nephrotoxicity and hypertension.

Following World War II, a large number of Navy personnel suffered from lead poisoning as a result of their jobs repainting the hulls of ships. The medical use of EDTA as a lead chelating agent was introduced. Unlike BAL, it is a synthetic amino acid and contains no mercaptans. EDTA side effects were not considered as severe as BAL.

In the 1960s, BAL was modified into DMSA, a related dithiol with far fewer side effects. DMSA quickly replaced both BAL and EDTA, becoming the US standard of care for the treatment of lead, arsenic, and mercury poisoning, which it remains today.

Research in the former Soviet Union led to the introduction of DMPS, another dithiol, as a mercury-chelating agent. The Soviets also introduced ALA, which is transformed by the body into the dithiol dihydrolipoic acid, a mercury- and arsenic-chelating agent. DMPS has experimental status in the US FDA, while ALA is a common nutritional supplement.

Since the 1970s, iron chelation therapy has been used as an alternative to regular phlebotomy to treat excess iron stores in people with haemochromatosis. It is also at the forefront of clinical autism treatment.

Other chelating agents have been discovered. They all function by making several chemical bonds with metal ions, thus rendering them much less chemically reactive. The resulting complex is water-soluble, allowing it to enter the bloodstream and be excreted harmlessly.

Calcium-disodium EDTA chelation is approved by the U.S. Food and Drug Administration (FDA) for treating lead poisoning and heavy metal toxicity.

In 1998, the U.S. Federal Trade Commission (FTC) pursued the American College for Advancement in Medicine (ACAM), an organization that promotes “complementary, alternative and integrative medicine” over their advertising of EDTA chelation therapy, with claims including “Chelation therapy is a safe, effective and relatively inexpensive treatment to restore blood flow in victims of atherosclerosis without surgery.” The FTC found that “scientific studies do not prove that EDTA chelation therapy is an effective treatment for atherosclerosis.”, and that the statements by the ACAM were false. In 1999, the ACAM agreed to stop misrepresenting chelation therapy as effective in treating heart disease, avoiding legal proceedings.

It seems there is some confusion these days as to who the true experts on treating autism are. With so many experimental new drugs, treatments and behavioral therapies, both seasoned doctors (who’ve found a new niche specializing in autism treatment) as well as coalitions of parents and naturopaths are vying for a place being recognized for making great leaps in treating autism.

The Chicago Tribune, for one, has been busy casting aspersions on the legitimacy of the “crusades” of apparent non-AMA doctors, experts, activists, etc.  Specfically, those led by Dr. Mayer Eisenstein and Dr. Mark Geier and his son David.

One of the issues in their recent stories is the use of Lupron to treat aggression in autistic children who have high levels of testosterone — a move which has been hugely controversial.  The treatment is slammed as “unproven and potentially damaging” in the Tribune. Another of their attacks goes: “In the absence of definitive answers, unproven treatments have proliferated, including diets that eliminate wheat and dairy, chelation drugs that leach metals out of the body, and treatment in hyperbaric oxygen chambers similar to those used to treat scuba divers with ‘the bends.’ ”

But what does the Chicago Tribune know, really? Do they have a team of staff doctors and scientists with real medical facts to trump these experimental new forays, or simply just…cynicism on their side? It seems the establishment has taken great pride in bashing anything that doesn’t bow to Big Pharma’s vaccination agenda.

Will there be a new “autism vaccine” coming out from our friends in the industry soon? I don’t think the parents, doctors and scientists who actually want to see true remedy from the dual spikes in vaccines and autism will really care. They’ll be too busy doing real scientific work aimed at getting these kids detoxed and free of epidemic neuropathies such as autism.

Chelation has shown positive results. See for yourself at www.AwakenNutrition.com

Chelation and clathration both facilitate the removal of heavy metal compounds from the body. But there are some distinct differences between the two. Although both techniques “neutralize” toxic heavy metals in the bloodstream, and orient them toward elimination from the body, the structure of the two differs to some extent.

If chelation (the term is from the Greek phrase for “claw like”) grabs onto the heavy metal compound and pulls it out of the body, clathration forms a “cage” which incorporates the offending compound into its own structure, effectively (if the process works according to maximum efficacy) imprisoning the substance and escorting it out via the elimination process.

Another difference is that chelation can be thought of as a more one dimensional process, where clathration is a more three dimensional one. In clathration, specifically-sequenced glycoproteins and peptides form a lattice or inclusion complex and multiple receptor sites attach to a toxic molecule with irreversible bonds, literally wrapping themselves around the toxic substance, preventing additional reactions with tissues and organs as it is eliminated from the body.

Chelation has been used since World War I, when it was developed to remove toxic gas particulates from the blood. Clathration is a much more recent discovery.

The similarities are obvious — both disable toxic heavy metal compounds. Both are utilized by various clinicians who are now engaged in progressive study and treatment of autism and autism-related disorders, such as Asberger’s and Rett Syndrome.  Both have produced varying degrees of results within the bodies of patients and test subjects.

There is no doubt that we will be hearing much about these two procedures in coming years where concerns treating heavy metal toxicity and autism and autism-related disorders.

Chelation therapy is catching on – and for good reason. It’s proving to restore needed balance to those suffering heavy metal toxicity, as well as autism and autistic-related disorders, which have been found to be related to heavy metal poisoning – particularly through methylmercury found in vaccines. Unfortunately, methylmercury is a common and quite dangerous environmental contaminant that ends up accumulating in the human body, with unpleasant results.

Methylmercury is a bioaccumulating substance – meaning, it makes its way up the food chain through fish and other organisms, such as bacteria, propagating its presence exponentially in the ecosphere. Mercury itself is a neurotoxic heavy metal, the symptoms of which can present as any number of other things. The best thing is to get tested if you suspect you’ve been exposed to mercury, or methylmercury (the version of mercury that bioaccumulates in fish).

Supporters of chelation therapy rely on the testimonies of people who’ve had it done. Many people claim that their lives were saved and their health improved because of chelation therapy. Opponents say the results aren’t clear enough. But neither are the results clear on the myriad of barely tested drugs out there on the pharmaceutical market, so – you decide.

And these aren’t the only claims. Supporters also claim that chelation therapy significantly improves blood flow through previously narrowed blood vessels in some patients. Another claim is that chelation therapy has restored lost bodily function and reduced pain in some cases. Whatever the case is, positive results are being shown

The process of chelation actually removes harmful metals from the bloodstream. In fact, chelation therapy is the only way to treat lead poisoning. But lead isn’t the only metal cleansed from the body through chelation therapy. A chelation agent will also bind with most metals, mineral deposits, calcium-based plaques and other chemical toxins. Because of its positive impact on the bloodstream, chelation therapy has proven to benefit a number of medical conditions, including atherosclerosis and arteriosclerosis.

What exactly is chelation?

Chelation is a well-known method of heavy metal and toxin removal in which a special chemical compound called a chelate – such as dimercaptosuccinic acid (DMSA), dimercaptopropane sulfonate (DMPS), or ethylene diaminetetraacetic acid (EDTA) – is given, usually intravenously. The chelate finds and forms a single attachment to the toxin with one reversible ionic bond. With that bond intact, the toxin is grabbed onto, pulled off the cell and carried from the body. However, the toxin is not neutralized during this process and is potentially able to attach to other cells on its way out.

That’s the traditional form of chelation therapy. Great strides are being made, namely with oral therapy, which provides a painless, easy way of self-administering treatment, and with positive results. A new oral chelation therapy from Awaken Nutrition provides a speciallypatented method of introducing chelating substances into the body. Made up of peptides such as glutamic, fulvic and tartaric acid, Awaken Nutrition oral chelation spray offers those suffering from heavy metal toxicity and/or autism or autism-related disorders (or those with loved ones with such afflictions) new hope for wellness.

Expert testimony: chelation benefits

And, the experts are weighing in on the benefits of chelation therapy.

“There is no question that chelation, taking the mercury out of the kids, is by far the most effective treatment available,” says psychologist Bernard Rimland of the Autism Research Institute in San Diego, as quoted in a recent article on MSNBC. He’s only one of many health professionals weighing in about chelation therapy’s benefits. Other practitioners prescribe caution, but they, too, are having to behold the affirmative evidence now coming in.

Janet Hightower, M.D. is one of a group of emerging doctors who have experienced mercury toxicity in her patients, and acted upon it. Many of her patients were complaining of dizzyness, hair loss, forgetfulness and fatigue. She had some of them tested (the hair test is very easy and relatively affordable), and voila! Mercury toxicity. Dr. Hightower knew the battle was on, and she especially took issue with the gulf between an unsuspecting public and a government and special interests too greedy or callous to provide adequate food labeling and warning – especially to pregnant mothers, who are most susceptible.

See for yourself the benefits and the hope being generated by Awaken Nutrition’s oral chelation therapy spray. It’s affordable, easy-to-use, doctor-recommended, and available to anyone seeking greater vitality and wellness, and an escape from heavy metal toxicity.

Read the rest of this entry »